Patent · US Active

Process for purifying liraglutide

US11459354B2 · kind B2 · utility

0Cited by
1References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 25, 2020
Grant dateOct 4, 2022
Priority date
Expiry dateSep 10, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/605
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides improved processes for purifying liraglutide. Liraglutide is purified via two sequential RP-HPLC purifications followed by a salt-exchange step, where a pH is kept constant in the first and second purification steps. In particular, the processes utilize a halogenated solvent in a sample preparation step, which provides better solubility and an environment suitable for decarboxylation for crude liraglutide prior to a RP-HPLC purification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.